These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 37674683)
1. The role of pharmacists in eliminating counterfeit medicines in Nigeria. Adigwe OP Front Public Health; 2023; 11():1170929. PubMed ID: 37674683 [TBL] [Abstract][Full Text] [Related]
2. Challenges Associated with Addressing Counterfeit Medicines in Nigeria: An Exploration of Pharmacists' Knowledge, Practices, and Perceptions. Adigwe OP; Onavbavba G; Wilson DO Integr Pharm Res Pract; 2022; 11():177-186. PubMed ID: 36561911 [TBL] [Abstract][Full Text] [Related]
3. Community pharmacists' perceptions, awareness and practices regarding counterfeit medicines: a cross-sectional survey in Alexandria, Egypt. Bashir A; Galal S; Ramadan A; Wahdan A; El-Khordagui L East Mediterr Health J; 2020 May; 26(5):556-564. PubMed ID: 32538449 [TBL] [Abstract][Full Text] [Related]
4. Perceived Prevalence, Awareness and Attitude towards Counterfeit Medicines among Community Pharmacists of Kathmandu Valley: A Descriptive Cross-sectional Study. Kafle S; Jha N; Bhandary S; Ravi Shankar P JNMA J Nepal Med Assoc; 2024 Jun; 62(275):427-432. PubMed ID: 39369416 [TBL] [Abstract][Full Text] [Related]
5. Fighting trafficking of falsified and substandard medicinal products in Russia. Fayzrakhmanov NF Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702 [TBL] [Abstract][Full Text] [Related]
6. Counterfeit drug demand: perceptions of policy makers and community pharmacists in Sudan. Alfadl AA; Hassali MA; Ibrahim MI Res Social Adm Pharm; 2013; 9(3):302-10. PubMed ID: 22835708 [TBL] [Abstract][Full Text] [Related]
7. Point-of-Care Anti-Counterfeit Medicines Technologies: Awareness and Utilization among Medical Practitioners in Eastern Nigeria. Iloh GU; Akodu BA; Emeka EA; Obi IV West Afr J Med; 2021 Nov; Vol. 38(11):1029-1035. PubMed ID: 34918894 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of community pharmacists' readiness to implement the Falsified Medicines Directive (Directive 2011/62/EC): an English cross-sectional survey with geospatial analysis. Barrett R BMJ Open; 2020 Jan; 10(1):e033405. PubMed ID: 31924640 [TBL] [Abstract][Full Text] [Related]
9. Assessment of knowledge, attitude, and practice on substandard and counterfeit pharmaceutical products among pharmacy professionals in Gondar City, North-West Ethiopia. Worku MC; Mitku ML; Ayenew W; Limenh LW; Ergena AE; Geremew DT; Bizuneh GK; Tefera BB; Mekonnen BA; Anagaw YK Curr Pharm Teach Learn; 2024 Oct; 16(10):102140. PubMed ID: 39002340 [TBL] [Abstract][Full Text] [Related]
10. Consumer and Community Pharmacists' Perceptions of Online Pharmacy Services in Uyo Metropolis, Nigeria. Ndem E; Udoh A; Awofisayo O; Bafor E Innov Pharm; 2019; 10(3):. PubMed ID: 34007568 [TBL] [Abstract][Full Text] [Related]
11. Community pharmacists' knowledge of substandard and falsified medicines in clinical practice: a cross-sectional survey in Saudi Arabia. Bashayr Ali A; Barrett R Int J Pharm Pract; 2023 Apr; 31(2):176-182. PubMed ID: 36748987 [TBL] [Abstract][Full Text] [Related]
12. Assessment of practices and awareness regarding the disposal of unwanted pharmaceutical products among community pharmacies: a cross-sectional study in Palestine. Nairat LL; Abahri NA; Hamdan YA; Abdel-Khaliq RT; Odeh SM; Abutaha S; Al-Jabi SW; Koni AA; Abushanab AS; Zyoud SH BMC Health Serv Res; 2023 Sep; 23(1):1035. PubMed ID: 37759203 [TBL] [Abstract][Full Text] [Related]
13. Combatting Substandard and Falsified Medicines: Public Awareness and Identification of Counterfeit Medications. El-Dahiyat F; Fahelelbom KMS; Jairoun AA; Al-Hemyari SS Front Public Health; 2021; 9():754279. PubMed ID: 34765583 [No Abstract] [Full Text] [Related]
14. Global perspective of the risks of falsified and counterfeit medicines: A critical review of the literature. Feeney AJ; Goad JA; Flaherty GT Travel Med Infect Dis; 2024; 61():102758. PubMed ID: 39218049 [TBL] [Abstract][Full Text] [Related]
15. How the quality of essential medicines is perceived and maintained through the pharmaceutical supply chain: A perspective from stakeholders in Nigeria. Amadi C; Tsui EK Res Social Adm Pharm; 2019 Nov; 15(11):1344-1357. PubMed ID: 30509851 [TBL] [Abstract][Full Text] [Related]
16. [The fight against counterfeit medicines in Africa: experience and role of pharmacists]. Chauvé M C R Biol; 2008 Dec; 331(12):982-5. PubMed ID: 19027699 [TBL] [Abstract][Full Text] [Related]
17. An exploration of counterfeit medicine surveillance strategies guided by geospatial analysis: lessons learned from counterfeit Avastin detection in the US drug supply chain. Cuomo RE; Mackey TK BMJ Open; 2014 Dec; 4(12):e006657. PubMed ID: 25468507 [TBL] [Abstract][Full Text] [Related]
18. Public health interventions to protect against falsified medicines: a systematic review of international, national and local policies. Hamilton WL; Doyle C; Halliwell-Ewen M; Lambert G Health Policy Plan; 2016 Dec; 31(10):1448-1466. PubMed ID: 27311827 [TBL] [Abstract][Full Text] [Related]
19. Perceptions and practices of pharmaceutical wholesalers surrounding counterfeit medicines in a developing country: a baseline survey. Khan MH; Akazawa M; Dararath E; Kiet HB; Sovannarith T; Nivanna N; Yoshida N; Kimura K BMC Health Serv Res; 2011 Nov; 11():306. PubMed ID: 22074046 [TBL] [Abstract][Full Text] [Related]
20. Health Professionals and Pharmacists Awareness and Attitude Towards Counterfeit Medicine. Chaudhary S J Nepal Health Res Counc; 2023 Dec; 21(2):219-225. PubMed ID: 38196211 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]